RadNet Acquires Gleamer for $270M, Boosts AI Imaging Reach

RadNet announced the acquisition of Gleamer for 270 million dollars on March 2, 2026. The company trades on the NASDAQ under the symbol RDNT. Gleamer is a French artificial intelligence company focused on medical imaging. The acquisition expands RadNet's artificial intelligence capabilities in diagnostic imaging. Gleamer provides a suite of FDA-cleared algorithms for X-ray and mammography analysis. These tools complement RadNet's existing DeepHealth platform. RadNet operates more than 350 imaging centers across the United States. The combined operations make RadNet the largest independent provider of AI-powered radiology tools worldwide. The transaction extends RadNet's geographic reach into Europe, where Gleamer has a presence in more than 30 countries. Investors responded positively to the deal. They viewed the acquisition as a step that strengthens RadNet's competitive edge in the medical imaging sector.